Page last updated: 2024-08-22

angiotensin ii and Cancer of Liver

angiotensin ii has been researched along with Cancer of Liver in 92 studies

Research

Studies (92)

Timeframe	Studies, this research(%)	All Research%
pre-1990	27 (29.35)	18.7374
1990's	34 (36.96)	18.2507
2000's	14 (15.22)	29.6817
2010's	12 (13.04)	24.3611
2020's	5 (5.43)	2.80

Authors

Authors	Studies
Idrees, M; Khalid, M; Manzoor, S	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Alini, M; Bernstein, A; Grad, S; Izadpanah, K; Kubosch, D; Kubosch, EJ; Lang, G; Li, Z; Richards, RG; Südkamp, N; Wystrach, L	1
Gu, Y; Han, Z; Li, C; Li, Z; Liu, P; Liu, Z; Ma, Y; Tao, J; Tu, Y; Wang, F	1
Chen, Y; Cheng, F; He, X; Huang, B; Li, J; Li, M; Qi, M; Wu, X; Zhang, C	1
Bai, YX; Lei, CG; Qi, R; Tang, N; Xing, X	1
Wei, W; Wu, HX; Xu, ZW; Yan, SX; Zhang, Y	1
Ager, EI; Christophi, C; Neo, J; Wen, SW	1
Baba, A; Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Shimizu, M; Shirakami, Y; Tanaka, T; Terakura, D; Tsurumi, H	1
Lam, MG; Rosenbaum, CE; Smits, ML; van den Bosch, MA; van den Hoven, AF; Verkooijen, HM	1
Fujii, K; Fujiwara, R; Kitayoshi, M; Kuniyasu, H; Luo, Y; Ohmori, H; Sasaki, T; Sato, S; Tanabe, E; Zhou, L	1
Lu, X; Pan, D; Qin, Y; Wang, S; Wang, X; Wu, C; Xu, S; Xu, X; Ye, G	1
Ager, EI; Christophi, C; Neo, J; Nguyen, L	1
Fan, F; Jiang, G; Liu, Z; Lu, Y; Shen, C; Tao, L; Tian, C; Wu, H	1
Greish, K; Maeda, H; Nagamitsu, A	1
Aihara, Y; Fukui, H; Ikenaka, Y; Kaji, K; Noguchi, R; Yoshiji, H	1
Arends, J; Büchert, M; Fasol, U; Fiedler, U; Frost, A; Mross, K; Scharr, D; Scheuenpflug, J	1
Chihara, Y; Denda, A; Fujii, K; Kuniyasu, H; Luo, Y; Ohmori, H; Sasahira, T; Shimomoto, T; Tatsumoto, N	1
Amaya, K; Fujimura, T; Fushida, S; Kayahara, M; Kitagawa, H; Miwa, K; Ninomiya, I; Nishimura, G; Ohta, T; Shimizu, K; Yi, S	2
Koh, T; Taniguchi, H; Yamagishi, H	1
Aizawa, K; Kiyonaga, H; Miyashita, K; Todoroki, H; Yamaguchi, K	1
Baba, Y; Hayashi, S; Ishikawa, T; Kamimura, T; Nomura, K; Oota, H; Yoshida, T	1
Arai, K; Iwasaki, Y; Katayanagi, S; Matsumoto, H; Miyamoto, H; Takahashi, K; Yamaguchi, T	1
Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Takeda, K; Togashi, T; Tsuchiya, A; Ushiki, T; Watanabe, K; Yoshida, T	1
Fukui, H; Ikenaka, Y; Kaji, K; Kitade, M; Noguchi, R; Tsujimoto, T; Uemura, M; Yoshiji, H	1
Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Takeda, K; Togashi, T; Tsuchiya, A; Watanabe, K; Yoshida, T	1
Hayashida, S; Kobayashi, T; Sugimoto, K	1
Abe, I; Hori, K; Saito, S; Sato, H; Suzuki, M	1
Fujimoto, S; Ishigami, H; Minami, T; Miyazaki, M; Ohyama, N; Okui, K; Takahashi, M	1
Kato, T; Murakami, Y; Tamakawa, Y	1
Elgeti, H; Luska, G	1
Arai, K; Iwasaki, Y; Kitamura, M	4
Hoshi, M; Sato, H	1
Jiang, XQ; Lu, XX; Yin, GF	1
Chan, M; Ho, SK; Johnson, PJ; Lau, WY; Leung, NW; Leung, WT; Li, AK; Lin, J; Metreweli, C	1
Angerson, WJ; Cooke, TG; Goldberg, JA; Leen, E; Leiberman, DP; McArdle, CS; Warren, H	1
Angerson, WJ; Cooke, TG; Goldberg, JA; Leen, E; McArdle, CS; Sutherland, GR; Warren, HW	1
Cahill, PA; Sitzmann, JV; Wu, Y	1
Hoshima, M; Koyama, H; Masuyama, M; Mugitani, T; Takada, A; Takahashi, T; Tanaka, H; Taniguchi, H	1
Brasier, AR; Li, J	1
Honda, N; Inoue, Y; Machida, K; Nishikawa, J; Ohtake, T; Sasaki, Y; Takagi, S	1
Allen-Mersh, TG; Carnochan, P; Dworkin, MJ	1
Arai, K; Iwasaki, Y; Kitamura, M; Nakajima, Y	1
Arai, H; Makita, F; Matsumoto, T; Mitsugi, S; Mori, M; Saitoh, S; Takagi, H; Yuasa, K	1
Arai, K; Iwasaki, Y; Ohashi, M; Takahashi, T	1
Allen-Mersh, TG; Burke, D; Carnochan, P; Davies, MM; Dworkin, MJ; Flower, MA; Hall, AD; McCready, VR; Mundy, J; Ott, RJ; Young, HE; Zweit, J	1
Ishikawa, T; Matsui, S; Matsuki, H; Matsuzawa, J; Mita, Y; Sato, S; Tashiro, K; Tashiro, S	1
Asami, S; Daikoku, Y; Miyashita, K; Saito, Y; Todoroki, H; Yamaguchi, K	1
Allen-Mersh, TG; Burke, D; Carnochan, P; Davies, MM; Dworkin, MJ; Flower, MA; Glover, C; McCready, VR; Ott, RJ; Zweit, J	1
Ekelund, L; Göthlin, J; Jonsson, N; Sjögren, HO	1
Hardy, KJ; Phillips, PA; Potocnik, SJ	1
Anderson, JH; Angerson, WJ; Cooke, TG; Goldberg, JA; Hemingway, DM; McArdle, CS	1
Anderson, JH; Bessent, RG; Cooke, TG; Goldberg, JA; Kerr, DJ; McArdle, CS; McKillop, JH; Stewart, I	1
Anderson, JR; Goldberg, JA; Kerr, DJ; McArdle, CS; Mckillop, J; Whatelely, AT; Wilmott, N	1
Chiba, T; Fujii, Y; Furukawa, N; Hongo, T; Horikoshi, Y; Igarashi, Y; Masui, H; Nakajima, H; Nasuda, K; Yajima, S	1
Angerson, W; Carter, R; Cooke, TG; Hemingway, D; McArdle, CS	1
Butler, JA; Trezona, T; Vargas, H	1
Asano, Y; Ido, K; Kawamoto, C; Kimura, K; Muto, S; Ohtani, M; Otabe, S; Sato, K	1
Bessent, RG; Bradnam, MS; Fenner, J; Goldberg, JA; Kerr, DJ; McArdle, CS; McKillop, JH; Thomson, JA	1
Fukuda, I; Furukawa, H; Hiratsuka, M; Imaoka, S; Ishikawa, O; Kabuto, T; Kameyama, M; Masutani, S; Ohigashi, H; Sasaki, Y	1
Bessent, RG; Goldberg, JA; Kerr, DJ; McArdle, CS; McKillop, JH; Murray, T; Willmott, N	1
Arai, K; Kitamura, M; Miyashita, K	1
Mai, M; Ogino, T; Ohta, T; Sawaguchi, K; Suga, T; Takahashi, Y	1
Gilligan, A; Knowles, BB; Prentki, M	1
Fukuda, I; Hiratsuka, M; Imaoka, S; Ishikawa, O; Kameyama, M; Masutani, S; Nagano, H; Ohashi, I; Ohigashi, H; Sasaki, Y	1
Coezy, ED; Corvol, P; Howlett, AC	1
Goldberg, JA; Kerr, DJ; McArdle, CS; McKillop, JH; Wilmott, N	1
Asai, T; Kitamura, T; Mai, M; Ogino, T; Ohta, T; Sawaguchi, K; Suga, T; Takahashi, Y; Ueda, H; Ueno, M	1
Matsumoto, S; Morita, S; Odani, R	1
Sato, H; Takahashi, H	1
Furukawa, H; Hiratsuka, M; Imaoka, S; Ishikawa, O; Iwanaga, T; Kabuto, T; Ohigashi, H; Sasaki, Y; Shibata, T; Yasuda, T	1
Arai, K; Kitamura, M; Kosaki, G; Miyashita, K	1
Fujita, Y; Kotani, R; Morita, S	1
Kusano, S; Motohashi, O; Nakayama, S; Ohta, S	1
Greeff, MC; Kew, MC; Leckie, BJ	1
Kai, Y; Koura, Y; Kurisu, Y; Kuroi, K; Maruyama, T	1
Burton, MA; Gray, BN; Hardy, N; Kelleher, DK; Klemp, PF	1
Aikou, T; Hokita, S; Maenohara, S; Shimazu, H; Takao, S; Tokushige, M	1
Kobayashi, M; Murata, M; Seki, M; Takagi, S; Wada, M	1
Bessent, RG; Bradnam, MS; Fenner, J; Goldberg, JA; Kerr, DJ; McArdle, CS; McKee, RF; McKillop, JH	1
Hasegawa, Y; Imaoka, S; Ishikawa, O; Iwanaga, T; Koyama, H; Nakano, S; Ohigashi, H; Sasaki, Y; Taniguchi, K; Terasawa, T	1
Iijima, S; Kanai, T; Monden, M; Mori, T; Okamura, J; Okuda, H; Sakon, M; Shimano, T; Umeshita, K; Watase, M	1
Goldberg, JA; Kerr, DJ; McArdle, CS; McKillop, JH; Willmott, N	1
Bessent, RG; Bradnam, MS; George, WD; Goldberg, JA; Haughton, DM; Kerr, DJ; McArdle, CS; McKillop, JH; Willmott, N	1
Bessent, RG; Bradnam, MS; George, WD; Goldberg, JA; Kerr, DJ; McArdle, CS; McKillop, JH; Willmott, N	1
Fujita, M; Hasegawa, Y; Imaoka, S; Ishikawa, O; Iwanaga, T; Koyama, H; Nakano, S; Ohigashi, H; Sasaki, Y	1
Hirasawa, K	1
Essers, U; Schulte, P; Schweikert, HU; Siegenthaler, W; Stiel, D; Vetter, W; Weidmann, P; Werning, C	1

Reviews

7 review(s) available for angiotensin ii and Cancer of Liver

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
The effect of intra-arterial angiotensin II on the hepatic tumor to non-tumor blood flow ratio for radioembolization: a systematic review. PloS one, 2014, Volume: 9, Issue:1 Topics: Angiotensin II; Embolization, Therapeutic; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Radioisotopes; Regional Blood Flow	2014
Impact of renin-angiotensin system in hepatocellular carcinoma. Current cancer drug targets, 2011, Volume: 11, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Renin-Angiotensin System	2011
Renin-angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases. Current medicinal chemistry, 2007, Volume: 14, Issue:26 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Carcinoma, Hepatocellular; Humans; Liver Cirrhosis; Liver Neoplasms; Neovascularization, Physiologic; Renin-Angiotensin System; Vascular Endothelial Growth Factor A	2007
[Angiographic methods for the diagnosis and therapy of liver diseases]. Rontgenpraxis; Zeitschrift fur radiologische Technik, 1980, Volume: 33, Issue:1 Topics: Angiography; Angiotensin II; Bradykinin; Hepatic Artery; Hepatic Veins; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Portacaval Shunt, Surgical; Portal Vein; Portography; Venous Pressure	1980
Hypertension as a paraneoplastic syndrome in hepatocellular carcinoma. Journal of gastroenterology, 1999, Volume: 34, Issue:4 Topics: Aged; Angiotensin I; Angiotensin II; Carcinoma, Hepatocellular; Fatal Outcome; Humans; Hypertension; Hypoglycemia; Liver Neoplasms; Male; Paraneoplastic Syndromes; Renin; Tomography, X-Ray Computed; Ultrasonography	1999
Hyperreninemic hypoaldosteronism due to hepatocellular carcinoma metastatic to the adrenal gland. Clinical nephrology, 1991, Volume: 35, Issue:2 Topics: Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Carcinoma, Hepatocellular; Furosemide; Humans; Hypoaldosteronism; Liver Neoplasms; Male; Middle Aged; Renin	1991

Trials

10 trial(s) available for angiotensin ii and Cancer of Liver

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:4 Topics: Adult; Aged; Angiogenesis Inhibitors; Angiotensin II; Area Under Curve; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Endothelin-1; Female; Humans; Interleukins; Liposomes; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Ultrasonography; Vascular Endothelial Growth Factor A	2012
Angiotensin-II administration is useful for the detection of liver metastasis from pancreatic cancer during pharmacoangiographic computed tomography. World journal of gastroenterology, 2007, Jun-14, Volume: 13, Issue:22 Topics: Adult; Aged; Aged, 80 and over; Angiography; Angiotensin II; Celiac Artery; Female; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Tomography, Spiral Computed; Vasoconstrictor Agents	2007
Angiotensin II-induced hypertension chemotherapy (IHC) for advanced gastrointestinal, pancreatic and hepatobiliary carcinoma. Internal medicine (Tokyo, Japan), 1995, Volume: 34, Issue:4 Topics: Angiotensin II; Biliary Tract Neoplasms; Gastrointestinal Neoplasms; Humans; Hypertension; Liver Neoplasms; Pancreatic Neoplasms	1995
[Hepatic hemodynamic changes in liver cancer patients during intrahepatic arterial angiotensin II infusion induced hypertension and chemoembolization]. Zhonghua wai ke za zhi [Chinese journal of surgery], 1994, Volume: 32, Issue:11 Topics: Angiotensin II; Blood Pressure; Chemoembolization, Therapeutic; Female; Hemodynamics; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Circulation; Liver Neoplasms; Male; Middle Aged; Ultrasonography, Doppler, Pulsed; Vascular Resistance	1994
Effect of angiotensin II on arteriovenous shunting assessed by hepatic arterial perfusion scintigraphy. American journal of clinical oncology, 1997, Volume: 20, Issue:3 Topics: Adult; Aged; Angiotensin II; Antineoplastic Agents; Arteriovenous Fistula; Drug Delivery Systems; Female; Humans; Infusions, Intra-Arterial; Liver Circulation; Liver Neoplasms; Male; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Aggregated Albumin; Tissue Distribution; Vasoconstrictor Agents	1997
62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases. European journal of nuclear medicine, 2001, Volume: 28, Issue:1 Topics: Algorithms; Angiotensin II; Calibration; Colorectal Neoplasms; Copper Radioisotopes; Humans; Image Processing, Computer-Assisted; Liver; Liver Circulation; Liver Neoplasms; Organometallic Compounds; Radiopharmaceuticals; Reproducibility of Results; Thiosemicarbazones; Tomography, Emission-Computed; Vasoconstrictor Agents; Zinc Radioisotopes	2001
[Evaluation of intra-arterial infusion chemotherapy for liver metastases and lymph node metastases from gastric cancer--comparative analysis for intra-arterial group and non-intra-arterial group]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:11 Topics: Angiotensin II; Antibiotics, Antineoplastic; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mitomycin; Prognosis; Stomach Neoplasms; Survival Rate	2001
Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastases. British journal of cancer, 2001, Nov-30, Volume: 85, Issue:11 Topics: Angiotensin II; Blood Flow Velocity; Blood Pressure; Colorectal Neoplasms; Copper Radioisotopes; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Organometallic Compounds; Reproducibility of Results; Thiosemicarbazones; Time Factors; Tomography, Emission-Computed; Vasoconstrictor Agents	2001
Regional chemotherapy for colorectal liver metastases: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases. The British journal of surgery, 1990, Volume: 77, Issue:11 Topics: Adult; Aged; Albumins; Angiotensin II; Colorectal Neoplasms; Drug Evaluation; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Microspheres; Middle Aged	1990

Other Studies

76 other study(ies) available for angiotensin ii and Cancer of Liver

Article	Year
P2X4 receptors mediate induction of antioxidants, fibrogenic cytokines and ECM transcripts; in presence of replicating HCV in in vitro setting: An insight into role of P2X4 in fibrosis. PloS one, 2022, Volume: 17, Issue:5 Topics: Angiotensin II; Animals; Antioxidants; Carcinoma, Hepatocellular; Cytokines; Elastin; Fibrosis; Hepacivirus; Hepatitis C; Humans; Laminin; Liver Neoplasms; Rats; Receptors, Purinergic P2X4; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha	2022
The tissue-renin-angiotensin-system of the human intervertebral disc. European cells & materials, 2020, 10-02, Volume: 40 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II; Carcinoma, Hepatocellular; Female; Gene Expression Regulation; Humans; Intervertebral Disc; Intervertebral Disc Degeneration; Liver Neoplasms; Male; Middle Aged; Renin-Angiotensin System; Young Adult	2020
AT1R-Specific Ligand Angiotensin II as a Novel SPECT Agent for Hepatocellular Carcinoma Diagnosis. ACS sensors, 2020, 12-24, Volume: 5, Issue:12 Topics: Angiotensin II; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Ligands; Liver Neoplasms; Mice; Rats; Tomography, Emission-Computed, Single-Photon	2020
Angiotensin II promotes EMT of hepatocellular carcinoma cells through high mobility group protein B1 mediated by E4F1. Biochemical and biophysical research communications, 2021, 04-02, Volume: 547 Topics: Angiotensin II; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; HMGB1 Protein; Humans; Liver Neoplasms; Repressor Proteins; Ubiquitin-Protein Ligases; Vasoconstrictor Agents	2021
The AT1/Raf/ERK1/2 signaling pathway is involved in Angiotensin II-enhanced proliferation of hepatic carcinoma cells. Neoplasma, 2019, Jan-15, Volume: 66, Issue:1 Topics: Angiotensin II; Carcinoma, Hepatocellular; Cell Proliferation; Hep G2 Cells; Humans; Liver Neoplasms; MAP Kinase Signaling System; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2	2019
Angiotensin II and tumor necrosis factor-α stimulate the growth, migration and invasion of BEL-7402 cells via down-regulation of GRK2 expression. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2019, Volume: 51, Issue:2 Topics: Angiotensin II; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Disease Progression; Down-Regulation; G-Protein-Coupled Receptor Kinase 2; Humans; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Receptor, Angiotensin, Type 1; Receptors, Tumor Necrosis Factor, Type I; Tumor Necrosis Factor-alpha	2019
The renin angiotensin system regulates Kupffer cells in colorectal liver metastases. Cancer biology & therapy, 2013, Volume: 14, Issue:8 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Colorectal Neoplasms; Disease Models, Animal; Gadolinium; Kupffer Cells; Liver Neoplasms; Macrophages; Male; Mice; Mice, Inbred CBA; Peptide Fragments; Renin-Angiotensin System	2013
Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions. Cancer letters, 2014, Jan-01, Volume: 342, Issue:1 Topics: Angiotensin II; Animals; Anticarcinogenic Agents; Catechin; Fatty Liver; Gene Expression; Hypertension; Interleukin-6; Lipid Peroxidation; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Peptidyl-Dipeptidase A; Precancerous Conditions; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Tumor Necrosis Factor-alpha	2014
Role of two types of angiotensin II receptors in colorectal carcinoma progression. Pathobiology : journal of immunopathology, molecular and cellular biology, 2014, Volume: 81, Issue:4 Topics: Aged; Angiotensin II; Animals; Cell Line, Tumor; Colorectal Neoplasms; Disease Progression; Female; Gene Knockout Techniques; Humans; Liver Neoplasms; Male; Mice; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2	2014
The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma. Biochemical and biophysical research communications, 2015, Mar-27, Volume: 459, Issue:1 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Antigens, CD34; Biomarkers, Tumor; Carcinoma, Hepatocellular; Case-Control Studies; Gene Expression Regulation, Neoplastic; Humans; Liver Cirrhosis; Liver Neoplasms; Peptide Fragments; Peptidyl-Dipeptidase A; Prognosis; Reference Values; Renin-Angiotensin System; Vascular Endothelial Growth Factor A	2015
Regulation of colorectal cancer cell epithelial to mesenchymal transition by the renin angiotensin system. Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:10 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Movement; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Humans; Liver Neoplasms; Matrix Metalloproteinase 9; Mice, Inbred CBA; Neoplasm Proteins; Neoplasm Transplantation; Nitric Oxide Synthase Type II; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Tumor Cells, Cultured	2016
Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 83 Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Humans; Liver Neoplasms; Mice, Nude; Neovascularization, Pathologic; Receptor, Angiotensin, Type 1; Tetrazoles; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2016
Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors. Japanese journal of clinical oncology, 2009, Volume: 39, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Angiotensin II; Antineoplastic Agents; Blood Pressure; Carcinoma, Renal Cell; Cholangiocarcinoma; Drug Delivery Systems; Female; Humans; Hypertension; Infusions, Intravenous; Japan; Kidney Neoplasms; Liver Neoplasms; Male; Maleic Anhydrides; Middle Aged; Neoplasm Staging; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Polystyrenes; Vasoconstrictor Agents; Zinostatin	2009
Diabetes-associated angiotensin activation enhances liver metastasis of colon cancer. Clinical & experimental metastasis, 2012, Volume: 29, Issue:8 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chymases; Colonic Neoplasms; Diabetes Complications; Diabetes Mellitus; Glucose; Glycated Hemoglobin; HT29 Cells; Humans; Hyperglycemia; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Oligoribonucleotides, Antisense; Receptor, Angiotensin, Type 1; Renin; RNA Interference; RNA, Small Interfering	2012
[Intrinsic angiotensin II-generating system in human pancreatic cancer tissues]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:12 Topics: Adult; Aged; Angiotensin II; Carcinoma, Hepatocellular; Colonic Neoplasms; Female; Histocytochemistry; Humans; Liver Neoplasms; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Peptidyl-Dipeptidase A	2002
Oxygen-15 positron-emission tomography for predicting selective delivery of a chemotherapeutic agent to hepatic cancers during angiotensin II-induced hypertension. Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:4 Topics: Adult; Aged; Angiotensin II; Blood Pressure; Carcinoma, Hepatocellular; Female; Hepatic Artery; Humans; Hypertension; Liver Circulation; Liver Neoplasms; Male; Middle Aged; Oxygen Radioisotopes; Portal Vein; Spleen; Tomography, Emission-Computed	2003
[A case of gastric cancer with liver metastasis in which obstruction of the bile duct and choledocholithiasis was caused by intra-hepatic arterial infusion chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:4 Topics: Angiotensin II; Cholestasis; Drug Administration Schedule; Drug Therapy, Combination; Gallstones; Gastrectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms	2003
Angiotensin converting enzyme-independent, local angiotensin II-generation in human pancreatic ductal cancer tissues. International journal of oncology, 2003, Volume: 23, Issue:3 Topics: Angiotensin II; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Chymases; Colonic Neoplasms; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Liver Neoplasms; Mast Cells; Pancreas; Pancreatic Neoplasms; Peptidyl-Dipeptidase A; Serine Endopeptidases; Trypsin	2003
[A case of advanced gastric cancer with liver and intra-abdominal lymph node metastasis treated by hypertensive selective chemotherapy with pharmacokinetic modulating chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:8 Topics: Adenocarcinoma; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Pancreatic Neoplasms; Stomach Neoplasms; Tegafur	2003
[A case of liver metastases from gastric cancer successfully treated with induced hypertensive chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:11 Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Brain Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Gastrectomy; Hepatectomy; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Proteoglycans; Radiosurgery; Stomach Neoplasms; Tegafur; Uracil	2003
Clinical efficacy of intra-arterial pharmacokinetic chemotherapy with 5-fluorouracil, CDDP, gemcitabine, and angiotensin-II in patients with advanced pancreatic cancer. Hepato-gastroenterology, 2007, Volume: 54, Issue:80 Topics: Angiotensin II; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Chemotherapy, Cancer, Regional Perfusion; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Treatment Outcome	2007
[The clinical effect of hyperthermia combined with induced hypertension chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:6 Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Pressure; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Hyperthermia, Induced; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasms; Peplomycin; Uterine Neoplasms; Vincristine	1984
New technique for measurement of microvascular pressure in normal and tumor vessels of rats. Invasion & metastasis, 1981, Volume: 1, Issue:4 Topics: Angiotensin II; Animals; Arteries; Blood Pressure; Blood Pressure Determination; Capillaries; Carcinoma, Hepatocellular; Liver Neoplasms; Male; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Rats; Rats, Inbred Strains	1981
[Clinical-pharmacological effects of angiotensin II upon intra-arterial infusion cancer chemotherapy (author's transl)]. Nihon Gan Chiryo Gakkai shi, 1981, Apr-20, Volume: 16, Issue:2 Topics: Angiotensin II; Antineoplastic Agents; Carcinoma, Hepatocellular; Humans; Infusions, Intra-Arterial; Liver Circulation; Liver Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms	1981
[Tumor vascularity under hypertension induced by intravenous infusion of angiotensin II. An angiographic observation]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1984, Aug-25, Volume: 44, Issue:8 Topics: Angiography; Angiotensin II; Humans; Hypertension; Infusions, Parenteral; Liver Neoplasms; Neoplasms; Rectal Neoplasms	1984
[A case of intrahepatic infusion chemotherapy with angiotensin II human for liver metastasis from early gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:11 Topics: Adenocarcinoma; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Female; Fluorouracil; Gastrectomy; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Stomach Neoplasms	1995
Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994, Volume: 35, Issue:1 Topics: Angiotensin II; Carcinoma, Hepatocellular; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Pulmonary Circulation; Technetium Tc 99m Aggregated Albumin	1994
Hepatic arterial haemodynamics changes following intra-arterial angiotensin II infusion: duplex/colour Doppler sonography. Clinical radiology, 1993, Volume: 47, Issue:5 Topics: Aged; Angiotensin II; Blood Flow Velocity; Colorectal Neoplasms; Hemodynamics; Hepatic Artery; Humans; Infusions, Intra-Arterial; Intraoperative Care; Liver Neoplasms; Middle Aged; Postoperative Care; Time Factors; Ultrasonography	1993
Duplex/colour Doppler sonography: measurement of changes in hepatic arterial haemodynamics following intra-arterial angiotensin II infusion. British journal of cancer, 1993, Volume: 67, Issue:6 Topics: Aged; Angiotensin II; Blood Pressure; Colorectal Neoplasms; Hemodynamics; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Circulation; Liver Neoplasms; Middle Aged; Ultrasonics; Ultrasonography; Vasoconstrictor Agents	1993
Decreased angiotensin II receptors mediate decreased vascular response in hepatocellular cancer. Annals of surgery, 1996, Volume: 223, Issue:2 Topics: Angiotensin II; Animals; Carcinoma, Hepatocellular; Hemodynamics; Hepatic Artery; Humans; Liver; Liver Neoplasms; Male; Radioligand Assay; Rats; Rats, Inbred ACI; Receptors, Angiotensin; Tumor Cells, Cultured	1996
Angiotensin-II-induced hypertension chemotherapy: evaluation of hepatic blood flow with oxygen-15 PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:9 Topics: Angiotensin II; Blood Pressure; Carcinoma, Hepatocellular; Female; Humans; Liver Circulation; Liver Neoplasms; Male; Middle Aged; Oxygen Radioisotopes; Recombinant Proteins; Tomography, Emission-Computed	1996
Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Molecular endocrinology (Baltimore, Md.), 1996, Volume: 10, Issue:3 Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Carcinoma, Hepatocellular; Enhancer Elements, Genetic; Feedback; Gene Expression Regulation; Humans; Liver; Liver Neoplasms; Macromolecular Substances; Models, Biological; NF-kappa B; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Renin-Angiotensin System; Signal Transduction; Transcription Factor RelA; Transcription Factor RelB; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	1996
[Induced hypertensive chemotherapy with angiotensin-II for liver metastases from gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:11 Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms	1996
Effect of continuous regional vasoactive agent infusion on liver metastasis blood flow. British journal of cancer, 1997, Volume: 76, Issue:9 Topics: Angiotensin II; Animals; Blood Pressure; Calcitonin Gene-Related Peptide; Disease Models, Animal; Endothelin-1; Infusions, Intra-Arterial; Laser-Doppler Flowmetry; Liver Circulation; Liver Neoplasms; Male; Mice; Mice, Inbred Strains; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins	1997
[Correlation between anti-tumor effects and serum hepatocyte growth factor level in patients with liver metastases from gastric cancer treated by induced hypertensive chemotherapy with angiotensin II]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:12 Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blood Pressure; CA-19-9 Antigen; Carcinoembryonic Antigen; Female; Fluorouracil; Hepatocyte Growth Factor; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Mitomycins; Stomach Neoplasms	1997
[Intrahepatic arterial infusion chemotherapy with angiotensin II for liver metastasis from gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:9 Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Drug Administration Schedule; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms	1998
[A case of liver metastases from gastric cancer responding to induced hypertensive chemotherapy with angiotensin II]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:8 Topics: Aged; Angiotensin II; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Drug Administration Schedule; Fluorouracil; Gastrectomy; Humans; Injections, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Methotrexate; Mitomycin; Neoplasm Recurrence, Local; Stomach Neoplasms; Vasoconstrictor Agents	1999
[Efficacy and problems of hepatic arterial chemotherapy with angiotensin II for liver metastasis from gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:12 Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Drug Administration Schedule; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Stomach Neoplasms	1999
[A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with angiotensin-II and administration of tegafur/uracil]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:4 Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Methotrexate; Middle Aged; Pancreatic Neoplasms; Tegafur; Uracil	2001
Pharmacoangiography in experimental tumours. Evaluation of vasoactive drugs. Acta radiologica: diagnosis, 1976, Volume: 17, Issue:3 Topics: Angiography; Angiotensin II; Animals; Colonic Neoplasms; Kidney Neoplasms; Liver Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Norepinephrine; Rats; Rats, Inbred Strains; Sarcoma, Experimental; Tolazoline; Vasopressins	1976
Human resistance artery reactivity is altered by liver transplantation and treatment with cyclosporin A. Transplantation proceedings, 1992, Volume: 24, Issue:5 Topics: Adipose Tissue; Angiotensin II; Arginine Vasopressin; Arteries; Cyclosporine; Humans; In Vitro Techniques; Liver Neoplasms; Liver Transplantation; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Vascular Resistance; Vasoconstriction	1992
Monitoring blood flow to colorectal liver metastases using laser Doppler flowmetry: the effect of angiotensin II. British journal of cancer, 1992, Volume: 66, Issue:5 Topics: Angiotensin II; Blood Pressure; Colorectal Neoplasms; Humans; Laser-Doppler Flowmetry; Liver Neoplasms; Monitoring, Physiologic; Regional Blood Flow; Systole	1992
Glass yttrium-90 microspheres for patients with colorectal liver metastases. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1992, Volume: 25, Issue:2 Topics: Angiotensin II; Colorectal Neoplasms; Glass; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Microspheres; Middle Aged; Radiotherapy Dosage; Yttrium Radioisotopes	1992
The effect of angiotensin II on tumor blood flow and the delivery of microparticulate cytotoxic drugs. EXS, 1992, Volume: 61 Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Colonic Neoplasms; Doxorubicin; Drug Carriers; Humans; Infusions, Intra-Arterial; Iodine Radioisotopes; Liver Neoplasms; Microspheres; Middle Aged; Mitomycin; Neoplasms, Unknown Primary; Radionuclide Imaging; Rectal Neoplasms; Regional Blood Flow; Technetium	1992
Angiotensin-induced hypertension chemotherapy in children with advanced solid tumors. Acta paediatrica Japonica : Overseas edition, 1991, Volume: 33, Issue:3 Topics: Adolescent; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Child; Child, Preschool; Coccyx; Female; Humans; Hypertension; Infant; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Staging; Neoplasms; Sacrum; Thoracic Neoplasms	1991
The combination of degradable starch microspheres and angiotensin II in the manipulation of drug delivery in an animal model of colorectal metastasis. British journal of cancer, 1992, Volume: 65, Issue:1 Topics: Angiotensin II; Animals; Colonic Neoplasms; Drug Carriers; Liver Neoplasms; Male; Microspheres; Neoplasm Metastasis; Radionuclide Imaging; Rats; Rats, Inbred Strains; Rectal Neoplasms; Sarcoma, Experimental; Starch; Technetium Tc 99m Medronate	1992
Angiotensin alteration of drug uptake in an experimental model of hepatic metastases. The Journal of surgical research, 1991, Volume: 51, Issue:2 Topics: Angiotensin II; Animals; Female; Floxuridine; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Rabbits; Tumor Cells, Cultured	1991
Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastases. British journal of cancer, 1991, Volume: 64, Issue:1 Topics: Angiotensin II; Colonic Neoplasms; Drug Carriers; Humans; Liver Neoplasms; Microspheres; Rectal Neoplasms; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed	1991
[Hepatic arterial infusion chemotherapy and loco-regional treatment and irradiation of pancreas tumor in non-resectable pancreas cancer with liver metastases]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:11 Topics: Administration, Oral; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Leucovorin; Liver Neoplasms; Methotrexate; Pancreatic Neoplasms; Radiotherapy, High-Energy	1991
The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour. British journal of cancer, 1991, Volume: 63, Issue:2 Topics: Adult; Aged; Angiotensin II; Antineoplastic Agents; Drug Carriers; Humans; Liver Neoplasms; Microspheres; Middle Aged	1991
[Evaluation of the liver and peritoneal metastasis in the treatment of gastric carcinoma with intra-arterial injection in terms of survival period]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 2 Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Mitomycins; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms; Survival Rate	1990
[Study of intraarteric infusion chemotherapy with drug delivery system]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 2 Topics: Aged; Angiotensin II; Antineoplastic Agents; Blood Pressure; Cisplatin; Doxorubicin; Drug Administration Routes; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms	1990
EGF receptor down-regulation attenuates ligand-induced second messenger formation. Experimental cell research, 1990, Volume: 187, Issue:1 Topics: Angiotensin II; Calcium; Carcinoma, Hepatocellular; Cell Line; Chromatography, High Pressure Liquid; Cytosol; Down-Regulation; Epidermal Growth Factor; ErbB Receptors; Flow Cytometry; Humans; Inositol Phosphates; Ligands; Liver Neoplasms; Molecular Weight; Second Messenger Systems	1990
[Chemoembolization for liver metastasis from colorectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 2 Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Embolization, Therapeutic; Humans; Iodized Oil; Liver Neoplasms; Prognosis; Survival Rate	1990
Involvement of a pertussis toxin-sensitive G protein in the regulation of angiotensinogen production by an angiotensin II analog in HepG2 cells. Cellular signalling, 1990, Volume: 2, Issue:1 Topics: Adenosine Diphosphate Ribose; Angiotensin II; Angiotensinogen; Carcinoma, Hepatocellular; Colforsin; Cyclic AMP; Glucagon; GTP-Binding Proteins; Humans; Liver Neoplasms; Neoplasm Proteins; Pertussis Toxin; Protein Processing, Post-Translational; Second Messenger Systems; Tumor Cells, Cultured; Virulence Factors, Bordetella	1990
[Combination of missile-induced hypertensive intra-aortic infusion chemotherapy in a patient with hepatocellular carcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:8 Topics: alpha-Fetoproteins; Angiotensin II; Blood Pressure; Carcinoma, Hepatocellular; Doxorubicin; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged	1986
[Hepatic artery infusion chemotherapy with cisplatin and adriamycin in combination with angiotensin-II in the treatment of malignant liver tumors]. Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:4 Pt 1 Topics: Adult; Aged; alpha-Fetoproteins; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Prognosis	1988
[Chemotherapeutic effect on metastatic tumors]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:4 Pt 2-1 Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Doxorubicin; Fluorouracil; Humans; Liver Neoplasms; Lymphatic Metastasis; Mitomycin; Mitomycins; Stomach Neoplasms	1989
[Preventive effects of intra-arterial infusion chemotherapy of liver metastasis in non-resectable pancreatic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:8 Pt 2 Topics: Alprostadil; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Pancreatic Neoplasms; Portal Vein	1989
[Arterial infusion chemotherapy in patients with gastric cancer in liver metastasis and long-term survival after treatment]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:8 Pt 2 Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Aorta; Doxorubicin; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Microspheres; Middle Aged; Mitomycin; Mitomycins; Remission Induction; Starch; Stomach Neoplasms	1989
[Pharmacoangiography of liver neoplasms and gallbladder arteries with angiotensin II]. Rinsho hoshasen. Clinical radiography, 1989, Volume: 34, Issue:2 Topics: Angiotensin II; Carcinoma, Hepatocellular; Embolization, Therapeutic; Gallbladder Diseases; Hepatic Artery; Humans; Liver Neoplasms; Radiographic Image Enhancement	1989
[The hepatic hemodynamic response to intra-arterial infusion of vasoactive agents--Part 2. Blood flow measurements in rats with liver cancer]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1989, Volume: 86, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Bucladesine; Infusions, Intra-Arterial; Liver Circulation; Liver Neoplasms; Prostaglandins F; Rats; Rats, Inbred Strains	1989
Arterial hypertension as a paraneoplastic phenomenon in hepatocellular carcinoma. Archives of internal medicine, 1989, Volume: 149, Issue:9 Topics: Adult; Angiotensin II; Carcinoma, Hepatocellular; Child; Humans; Hypertension; Liver Neoplasms; Male; Paraneoplastic Syndromes; Renin	1989
[Intra-arterial infusion chemotherapy in non-resectable pancreatic cancer using angiotensin-II and implantable drug delivery system]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:8 Pt 2 Topics: Adenoma, Bile Duct; Adult; Aged; Aged, 80 and over; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Fluorouracil; Humans; Infusion Pumps; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Pancreatic Neoplasms	1989
Selective internal radiation therapy: distribution of radiation in the liver. European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:10 Topics: Adenocarcinoma; Angiotensin II; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver; Liver Neoplasms; Microspheres; Radiotherapy Dosage; Yttrium Radioisotopes	1989
[Two-route chemotherapy under AT-II induced hypertension using totally implanted injection port system in liver metastases derived from digestive cancers]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:8 Pt 2 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Blood Pressure; Cisplatin; Female; Gastrointestinal Neoplasms; Humans; Infusion Pumps; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Remission Induction; Thiosulfates	1989
[Intra-arterial chemotherapy with angiotensin II in metastatic carcinoma of the liver using implantable pump]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:8 Pt 2 Topics: Adult; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Doxorubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Remission Induction	1989
Clinical evaluation of angiotensin II enhanced perfusion scintigraphy in metastatic liver disease. Nuclear medicine communications, 1989, Volume: 10, Issue:8 Topics: Angiotensin II; Diagnosis, Differential; Evaluation Studies as Topic; Gastrointestinal Neoplasms; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Neoplasms; Perfusion; Radionuclide Imaging	1989
Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer, 1985, Jan-15, Volume: 55, Issue:2 Topics: Adenocarcinoma; Aged; Angiotensin II; Antineoplastic Agents; Blood Pressure; Carcinoma, Hepatocellular; Female; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Krypton; Liver Circulation; Liver Neoplasms; Male; Middle Aged; Radioisotopes; Radionuclide Imaging	1985
[A case of multiple liver metastases from sigmoid carcinoma treated successfully with arterial infusion chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:7 Topics: Adenocarcinoma; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Drug Administration Schedule; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymph Node Excision; Middle Aged; Mitomycin; Mitomycins; Postoperative Period; Sigmoid Neoplasms; Urokinase-Type Plasminogen Activator	1986
Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases. British journal of cancer, 1988, Volume: 57, Issue:2 Topics: Albumins; Angiotensin II; Colonic Neoplasms; Fluorouracil; Hepatic Artery; Humans; Injections, Intra-Arterial; Leukocyte Count; Liver Neoplasms; Microspheres; Platelet Count; Rectal Neoplasms; Time Factors	1988
Arteriovenous shunting of microspheres in patients with colorectal liver metastases: errors in assessment due to free pertechnetate, and the effect of angiotensin II. Nuclear medicine communications, 1987, Volume: 8, Issue:12 Topics: Angiotensin II; Arteriovenous Anastomosis; Colonic Neoplasms; Humans; Liver; Liver Neoplasms; Microspheres; Radionuclide Imaging; Technetium; Technetium Compounds; Technetium Tc 99m Aggregated Albumin; Tin; Tin Compounds	1987
Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases: improved tumour targetting by microspheres with angiotensin II. Nuclear medicine communications, 1987, Volume: 8, Issue:12 Topics: Angiotensin II; Colonic Neoplasms; Embolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed	1987
[An effect of the intra-arterial infusion of angiotensin II in the chemotherapy of human hepatic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:4 Pt 2 Topics: Angiography; Angiotensin II; Antineoplastic Agents; Humans; Infusions, Intra-Arterial; Liver; Liver Neoplasms; Regional Blood Flow	1986
[Studies on renin-angiotensin system. I. Angiotensinase activities in hepatic disorders]. Japanese circulation journal, 1968, Volume: 32, Issue:3 Topics: Adult; Angiotensin II; Animals; Bile Duct Neoplasms; Biliary Tract Diseases; Blood Pressure; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Chloramphenicol; Endopeptidases; Erythromycin; Female; Gout; Hepatitis; Humans; Hypertension; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms; Male; Mercaptopurine; Middle Aged; Nephrotic Syndrome; Rats	1968
[Erythropoietin, renin, aldosterone, and blood volume in primary and secondary polycythemia]. Klinische Wochenschrift, 1971, Volume: 49, Issue:1 Topics: Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Blood Volume; Blood Volume Determination; Diuretics; Erythropoietin; Female; Hemoglobins; Humans; Hypoxia; Liver Neoplasms; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Plasma; Polycythemia; Posture; Renin	1971